Clinical Trial Update: A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dupilumab in young children with eosinophilic esophagitis is currently recruiting, sponsored by Regeneron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Dupilumab (Dupixent) (Dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Eosinophilic Esophagitis (EoE) | Phase 3 | Status: RECRUITING